The survival outcomes of localized low‐risk prostate cancer, a population‐based study using <scp>NCDB</scp>
This study highlights the differences in survival outcomes among LRPC treatment modalities. RP was associated with improved survival compared to NLT, especially in younger patients. In contrast, EBRT and PSI showed survival benefits primarily in the older age groups. NLT is a reasonable choice, particularly in younger patients when RP is not chosen. These findings emphasize the importance of individualized treatment decisions for LRPC management.
Authors
- John Lyne
- Yue Yin (ORCID: https://orcid.org/0000-0001-6497-5382)
- Ángela Sanguino
- Rodney E. Wegner (ORCID: https://orcid.org/0000-0003-2416-3499)
- Arash Samiei (ORCID: https://orcid.org/0000-0001-5078-2125)
- Shifeng S. Mao (ORCID: https://orcid.org/0000-0001-9532-0303)
- Ralph Miller
- Jeffrey Cohen
Institutions
- Allegheny Health Network (US)
- Allegheny-Singer Research Institute (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/cam4.70060
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42